B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GRM2

MOLECULAR TARGET

glutamate metabotropic receptor 2

UniProt: Q14416NCBI Gene: 29127 compounds

GRM2 (glutamate metabotropic receptor 2) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GRM2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Glutamic Acid3.0420
2Glutamic Acid3.0420
3eglumetad3.0420
4bdb whuutdbjxjrkmk2.208
5ly 3792682.087
6bdb 2 amino bicyclo 2 1 1 hexane 2 5 dicarboxylic acid abhxd i chembl905010.691
7bdb chembl21125860.691

About GRM2 as a Drug Target

GRM2 (glutamate metabotropic receptor 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented GRM2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GRM2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.